{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:13:11Z","timestamp":1785337991633,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,26]]},"DOI":"10.7759\/cureus.86829","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:46:51Z","timestamp":1751003211000},"source":"Crossref","is-referenced-by-count":1,"title":["MRI-Derived Tumor Characteristics As Prognostic Indicators in Prostate Cancer With Bone Metastases: A Preliminary Study"],"prefix":"10.7759","author":[{"given":"Hiroaki","family":"Koyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64073-6","article-title":"Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China","volume":"10","author":"Liu D","year":"2020","unstructured":"Liu D, Kuai Y, Zhu R, Zhou C, Tao Y, Han W, Chen Q. Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China. Sci Rep. 2020, 10:9104. 10.1038\/s41598-020-64073-6","journal-title":"Sci Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.03.034","article-title":"Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007)","volume":"184","author":"N\u00f8rgaard M","year":"2010","unstructured":"N\u00f8rgaard M, Jensen A\u00d8, Jacobsen JB, Cetin K, Fryzek JP, S\u00f8rensen HT. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol. 2010, 184:162-7. 10.1016\/j.juro.2010.03.034","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2021.07.016","article-title":"Multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: an updated systematic review","volume":"33","author":"Haider MA","year":"2021","unstructured":"Haider MA, Brown J, Yao X, Chin J, Perlis N, Schieda N, Loblaw A. Multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: an updated systematic review. Clin Oncol (R Coll Radiol). 2021, 33:e599-612. 10.1016\/j.clon.2021.07.016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27546","article-title":"Performance of Prostate Imaging Reporting and Data System version 2.1 for diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"54","author":"Park KJ","year":"2021","unstructured":"Park KJ, Choi SH, Kim MH, Kim JK, Jeong IG. Performance of Prostate Imaging Reporting and Data System version 2.1 for diagnosis of prostate cancer: a systematic review and meta-analysis. J Magn Reson Imaging. 2021, 54:103-12. 10.1002\/jmri.27546","journal-title":"J Magn Reson Imaging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.23219","article-title":"Clinically significant prostate cancer detection with biparametric MRI: a systematic review and meta-analysis","volume":"216","author":"Cuocolo R","year":"2021","unstructured":"Cuocolo R, Verde F, Ponsiglione A, Romeo V, Petretta M, Imbriaco M, Stanzione A. Clinically significant prostate cancer detection with biparametric MRI: a systematic review and meta-analysis. AJR Am J Roentgenol. 2021, 216:608-21. 10.2214\/AJR.20.23219","journal-title":"AJR Am J Roentgenol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38878-0","article-title":"MR imaging features to predict the type of bone metastasis in prostate cancer","volume":"13","author":"Koyama H","year":"2023","unstructured":"Koyama H, Kurokawa R, Kato S, et al.. MR imaging features to predict the type of bone metastasis in prostate cancer. Sci Rep. 2023, 13:11580. 10.1038\/s41598-023-38878-0","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System Version 2.1: 2019 update of Prostate Imaging Reporting and Data System Version 2","volume":"76","author":"Turkbey B","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, et al.. Prostate Imaging Reporting and Data System Version 2.1: 2019 update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019, 76:340-51. 10.1016\/j.eururo.2019.02.033","journal-title":"Eur Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.62347\/BODM5001","article-title":"Prognostic significance of the PI-RADS score in men with prostate cancer undergoing radical prostatectomy","volume":"12","author":"Nwanze J","year":"2024","unstructured":"Nwanze J, Teramoto Y, Wang Y, Miyamoto H. Prognostic significance of the PI-RADS score in men with prostate cancer undergoing radical prostatectomy. Am J Clin Exp Urol. 2024, 12:162-72. 10.62347\/BODM5001","journal-title":"Am J Clin Exp Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.11.065","article-title":"The impact of clinical stage on prostate cancer survival following radical prostatectomy","volume":"189","author":"Tollefson MK","year":"2013","unstructured":"Tollefson MK, Karnes RJ, Rangel LJ, Bergstralh EJ, Boorjian SA. The impact of clinical stage on prostate cancer survival following radical prostatectomy. J Urol. 2013, 189:1707-12. 10.1016\/j.juro.2012.11.065","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.210875","article-title":"Local extent of prostate cancer at MRI versus prostatectomy histopathology: associations with long-term oncologic outcomes","volume":"302","author":"Wibmer AG","year":"2022","unstructured":"Wibmer AG, Nikolovski I, Chaim J, et al.. Local extent of prostate cancer at MRI versus prostatectomy histopathology: associations with long-term oncologic outcomes. Radiology. 2022, 302:595-602. 10.1148\/radiol.210875","journal-title":"Radiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.771864","article-title":"The quantitative assessment of using multiparametric MRI for prediction of extraprostatic extension in patients undergoing radical prostatectomy: a systematic review and meta-analysis","volume":"11","author":"Li W","year":"2021","unstructured":"Li W, Sun Y, Wu Y, Lu F, Xu H. The quantitative assessment of using multiparametric MRI for prediction of extraprostatic extension in patients undergoing radical prostatectomy: a systematic review and meta-analysis. Front Oncol. 2021, 11:771864. 10.3389\/fonc.2021.771864","journal-title":"Front Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-020-02913-9","article-title":"Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer","volume":"46","author":"Valentin B","year":"2021","unstructured":"Valentin B, Schimm\u00f6ller L, Ullrich T, et al.. Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer. Abdom Radiol (NY). 2021, 46:2751-9. 10.1007\/s00261-020-02913-9","journal-title":"Abdom Radiol (NY)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0b013e3181b4c10e","article-title":"Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla","volume":"44","author":"Gibbs P","year":"2009","unstructured":"Gibbs P, Liney GP, Pickles MD, Zelhof B, Rodrigues G, Turnbull LW. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol. 2009, 44:572-6. 10.1097\/RLI.0b013e3181b4c10e","journal-title":"Invest Radiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11091409","article-title":"Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer","volume":"259","author":"Hambrock T","year":"2011","unstructured":"Hambrock T, Somford DM, Huisman HJ, et al.. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology. 2011, 259:453-61. 10.1148\/radiol.11091409","journal-title":"Radiology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.15.15894","article-title":"Preoperative evaluation of prostate cancer aggressiveness: using ADC and ADC ratio in determining Gleason score","volume":"207","author":"Woo S","year":"2016","unstructured":"Woo S, Kim SY, Cho JY, Kim SH. Preoperative evaluation of prostate cancer aggressiveness: using ADC and ADC ratio in determining Gleason score. AJR Am J Roentgenol. 2016, 207:114-20. 10.2214\/AJR.15.15894","journal-title":"AJR Am J Roentgenol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1789-3","article-title":"Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy","volume":"34","author":"Renard Penna R","year":"2016","unstructured":"Renard Penna R, Cancel-Tassin G, Comperat E, et al.. Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy. World J Urol. 2016, 34:1389-95. 10.1007\/s00345-016-1789-3","journal-title":"World J Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10100667","article-title":"Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?","volume":"258","author":"Turkbey B","year":"2011","unstructured":"Turkbey B, Shah VP, Pang Y, et al.. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?. Radiology. 2011, 258:488-95. 10.1148\/radiol.10100667","journal-title":"Radiology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/21681805.2017.1414872","article-title":"Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology","volume":"52","author":"Tonttila PP","year":"2018","unstructured":"Tonttila PP, Kuisma M, P\u00e4\u00e4kk\u00f6 E, Hirvikoski P, Vaarala MH. Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology. Scand J Urol. 2018, 52:111-5. 10.1080\/21681805.2017.1414872","journal-title":"Scand J Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00693-z","article-title":"MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients","volume":"27","author":"Baboudjian M","year":"2024","unstructured":"Baboudjian M, Uleri A, Beauval JB, et al.. MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients. Prostate Cancer Prostatic Dis. 2024, 27:318-22. 10.1038\/s41391-023-00693-z","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2020.08.089","article-title":"Multiparametric magnetic resonance imaging should be preferred over digital rectal examination for prostate cancer local staging and disease risk classification","volume":"147","author":"Soeterik TF","year":"2021","unstructured":"Soeterik TF, van Melick HH, Dijksman LM, Biesma DH, Witjes JA, van Basten JA. Multiparametric magnetic resonance imaging should be preferred over digital rectal examination for prostate cancer local staging and disease risk classification. Urology. 2021, 147:205-12. 10.1016\/j.urology.2020.08.089","journal-title":"Urology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7796.152118","article-title":"Prostate-specific antigen density as a parameter for the prediction of positive lymph nodes at radical prostatectomy","volume":"7","author":"Yiakoumos T","year":"2015","unstructured":"Yiakoumos T, K\u00e4lble T, Rausch S. Prostate-specific antigen density as a parameter for the prediction of positive lymph nodes at radical prostatectomy. Urol Ann. 2015, 7:433-7. 10.4103\/0974-7796.152118","journal-title":"Urol Ann"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-014-0367-0","article-title":"Clinical utility of the normalized apparent diffusion coefficient for preoperative evaluation of the aggressiveness of prostate cancer","volume":"32","author":"Itatani R","year":"2014","unstructured":"Itatani R, Namimoto T, Yoshimura A, et al.. Clinical utility of the normalized apparent diffusion coefficient for preoperative evaluation of the aggressiveness of prostate cancer. Jpn J Radiol. 2014, 32:685-91. 10.1007\/s11604-014-0367-0","journal-title":"Jpn J Radiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702","article-title":"Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3","volume":"34","author":"Scher HI","year":"2016","unstructured":"Scher HI, Morris MJ, Stadler WM, et al.. Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016, 34:1402-18. 10.1200\/JCO.2015.64.2702","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190480","article-title":"Accuracy of multiparametric magnetic resonance imaging for detecting extracapsular extension in prostate cancer: a systematic review and meta-analysis","volume":"92","author":"Zhang F","year":"2019","unstructured":"Zhang F, Liu CL, Chen Q, Shao SC, Chen SQ. Accuracy of multiparametric magnetic resonance imaging for detecting extracapsular extension in prostate cancer: a systematic review and meta-analysis. Br J Radiol. 2019, 92:20190480. 10.1259\/bjr.20190480","journal-title":"Br J Radiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.19.21836","article-title":"Prognostic value of pretreatment MRI in patients with prostate cancer treated with radiation therapy: a systematic review and meta-analysis","volume":"214","author":"Woo S","year":"2020","unstructured":"Woo S, Han S, Kim TH, et al.. Prognostic value of pretreatment MRI in patients with prostate cancer treated with radiation therapy: a systematic review and meta-analysis. AJR Am J Roentgenol. 2020, 214:597-604. 10.2214\/AJR.19.21836","journal-title":"AJR Am J Roentgenol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12029-8","article-title":"Pretreatment prostate-specific antigen density as a predictor of biochemical recurrence in patients with prostate cancer: a meta-analysis","volume":"24","author":"Cui F","year":"2024","unstructured":"Cui F, Qiu Y, Xu W, Zou C, Fan Y. Pretreatment prostate-specific antigen density as a predictor of biochemical recurrence in patients with prostate cancer: a meta-analysis. BMC Cancer. 2024, 24:305. 10.1186\/s12885-024-12029-8","journal-title":"BMC Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)37393-7","article-title":"Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer","volume":"147","author":"Benson MC","year":"1992","unstructured":"Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol. 1992, 147:815-6. 10.1016\/s0022-5347(17)37393-7","journal-title":"J Urol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-014-0696-0","article-title":"Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy","volume":"20","author":"Koie T","year":"2015","unstructured":"Koie T, Mitsuzuka K, Yoneyama T, et al.. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy. Int J Clin Oncol. 2015, 20:176-81. 10.1007\/s10147-014-0696-0","journal-title":"Int J Clin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.06.106","article-title":"Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer","volume":"66","author":"Brassell SA","year":"2005","unstructured":"Brassell SA, Kao TC, Sun L, Moul JW. Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer. Urology. 2005, 66:1229-33. 10.1016\/j.urology.2005.06.106","journal-title":"Urology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.21873\/cdp.10075","article-title":"Preoperative predictors of lymph node invasion and biochemical recurrence in high-risk prostate cancer","volume":"2","author":"Shida Y","year":"2022","unstructured":"Shida Y, Hakariya T, Mitsunari K, Matsuo T, Ohba K, Miyata Y, Sakai H. Preoperative predictors of lymph node invasion and biochemical recurrence in high-risk prostate cancer. Cancer Diagn Progn. 2022, 2:49-54. 10.21873\/cdp.10075","journal-title":"Cancer Diagn Progn"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202201_27863","article-title":"Risk factors of bone metastasis in patients with newly diagnosed prostate cancer","volume":"26","author":"Chaoying L","year":"2022","unstructured":"Chaoying L, Chao M, Xiangrui Y, Yingjian H, Gang Z, Yunhan R, Yu G. Risk factors of bone metastasis in patients with newly diagnosed prostate cancer. Eur Rev Med Pharmacol Sci. 2022, 26:391-8. 10.26355\/eurrev_202201_27863","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26933","article-title":"Histopathological features of MRI-invisible regions of prostate cancer lesions","volume":"51","author":"van Houdt PJ","year":"2020","unstructured":"van Houdt PJ, Ghobadi G, Schoots IG, et al.. Histopathological features of MRI-invisible regions of prostate cancer lesions. J Magn Reson Imaging. 2020, 51:1235-46. 10.1002\/jmri.26933","journal-title":"J Magn Reson Imaging"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.21037\/qims.2020.01.06","article-title":"Spatial density and diversity of architectural histology in prostate cancer: influence on diffusion weighted magnetic resonance imaging","volume":"10","author":"Harmon SA","year":"2020","unstructured":"Harmon SA, Brown GT, Sanford T, et al.. Spatial density and diversity of architectural histology in prostate cancer: influence on diffusion weighted magnetic resonance imaging. Quant Imaging Med Surg. 2020, 10:326-39. 10.21037\/qims.2020.01.06","journal-title":"Quant Imaging Med Surg"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","author":"Kweldam CF","year":"2016","unstructured":"Kweldam CF, K\u00fcmmerlin IP, Nieboer D, et al.. Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy. Mod Pathol. 2016, 29:630-6. 10.1038\/modpathol.2016.49","journal-title":"Mod Pathol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/his.14658","article-title":"Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies","volume":"80","author":"Rijstenberg LL","year":"2022","unstructured":"Rijstenberg LL, Hansum T, Kweldam CF, K\u00fcmmerlin IP, Remmers S, Roobol MJ, van Leenders GJ. Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies. Histopathology. 2022, 80:1041-9. 10.1111\/his.14658","journal-title":"Histopathology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051372","article-title":"Prostate cancer morphologies: cribriform pattern and intraductal carcinoma relations to adverse pathological and clinical outcomes: systematic review and meta-analysis","volume":"15","author":"Osiecki R","year":"2023","unstructured":"Osiecki R, Kozikowski M, Sarecka-Hujar B, Pyzlak M, Dobruch J. Prostate cancer morphologies: cribriform pattern and intraductal carcinoma relations to adverse pathological and clinical outcomes: systematic review and meta-analysis. Cancers (Basel). 2023, 15:1372. 10.3390\/cancers15051372","journal-title":"Cancers (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375557-mri-derived-tumor-characteristics-as-prognostic-indicators-in-prostate-cancer-with-bone-metastases-a-preliminary-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:46:52Z","timestamp":1751003212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375557-mri-derived-tumor-characteristics-as-prognostic-indicators-in-prostate-cancer-with-bone-metastases-a-preliminary-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.86829","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}